ASX - By Stock
|
RFX |
Re:
Redflow NEWS & EVENTS
|
|
idontknow
|
1.7K |
555K |
5 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
1.7K
|
555K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
idontknow
|
907 |
288K |
3 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
907
|
288K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Biotech Showcase 2023 Presentation in San Francisco
|
|
idontknow
|
179 |
70K |
0 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
179
|
70K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
idontknow
|
1.5K |
508K |
7 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
1.5K
|
508K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
idontknow
|
10K |
3.0M |
7 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Reduces Biomarkers for Mortality in SR-aGVHD
|
|
idontknow
|
139 |
72K |
4 |
20/12/20 |
20/12/20 |
ASX - By Stock
|
139
|
72K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
idontknow
|
1.0K |
419K |
7 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
419K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
idontknow
|
572 |
252K |
0 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
572
|
252K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
idontknow
|
572 |
252K |
6 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
572
|
252K
|
6
|
|
Breaking News
|
|
Re:
BREAKING EXCLUSIVE: WE GOT IT! — Col. Waldron (ELECTION DATA!)
|
|
idontknow
|
7 |
1.7K |
2 |
02/12/20 |
02/12/20 |
Breaking News
|
7
|
1.7K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Covid Long Haulers
|
|
idontknow
|
21 |
7.1K |
11 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
21
|
7.1K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
idontknow
|
17K |
6.8M |
2 |
22/11/20 |
22/11/20 |
ASX - By Stock
|
17K
|
6.8M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
|
|
idontknow
|
445 |
195K |
9 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
445
|
195K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
|
|
idontknow
|
445 |
195K |
3 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
445
|
195K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
|
|
idontknow
|
445 |
195K |
18 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
445
|
195K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
idontknow
|
635 |
279K |
5 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
635
|
279K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
idontknow
|
13K |
5.0M |
1 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
idontknow
|
13K |
5.0M |
43 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
43
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ethics Approval to Treat COVID-19 Patients in Australia
|
|
idontknow
|
320 |
130K |
13 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
320
|
130K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ethics Approval to Treat COVID-19 Patients in Australia
|
|
idontknow
|
320 |
130K |
5 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
320
|
130K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
idontknow
|
13K |
5.0M |
11 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
idontknow
|
2.0K |
696K |
5 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
696K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
idontknow
|
2.0K |
696K |
13 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
696K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
idontknow
|
2.0K |
696K |
3 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
696K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
idontknow
|
17K |
6.8M |
23 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
17K
|
6.8M
|
23
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
idontknow
|
23K |
13M |
2 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
idontknow
|
23K |
13M |
13 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
23K
|
13M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
idontknow
|
17K |
6.8M |
6 |
24/05/20 |
24/05/20 |
ASX - By Stock
|
17K
|
6.8M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
idontknow
|
17K |
6.8M |
6 |
24/05/20 |
24/05/20 |
ASX - By Stock
|
17K
|
6.8M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 ARDS and ARDS Share Price Scenarios
|
|
idontknow
|
518 |
265K |
3 |
24/05/20 |
24/05/20 |
ASX - By Stock
|
518
|
265K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
idontknow
|
17K |
6.8M |
6 |
23/05/20 |
23/05/20 |
ASX - By Stock
|
17K
|
6.8M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
idontknow
|
17K |
6.8M |
5 |
23/05/20 |
23/05/20 |
ASX - By Stock
|
17K
|
6.8M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Market Timing
|
|
idontknow
|
23 |
9.2K |
10 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
23
|
9.2K
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
idontknow
|
23K |
13M |
6 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Competition? What Competition?
|
|
idontknow
|
73 |
32K |
3 |
17/05/20 |
17/05/20 |
ASX - By Stock
|
73
|
32K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Capital raising
|
|
idontknow
|
197 |
72K |
19 |
17/05/20 |
17/05/20 |
ASX - By Stock
|
197
|
72K
|
19
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
idontknow
|
23K |
13M |
2 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
idontknow
|
23K |
13M |
6 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
idontknow
|
23K |
13M |
3 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
idontknow
|
23K |
13M |
8 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
idontknow
|
23K |
13M |
0 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
idontknow
|
23K |
13M |
7 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
23K
|
13M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
idontknow
|
23K |
13M |
25 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
23K
|
13M
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Tomorrow’s Shareprice
|
|
idontknow
|
77 |
44K |
1 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
77
|
44K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
idontknow
|
933 |
437K |
45 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
933
|
437K
|
45
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
idontknow
|
23K |
13M |
16 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
23K
|
13M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
idontknow
|
17K |
6.8M |
17 |
07/05/20 |
07/05/20 |
ASX - By Stock
|
17K
|
6.8M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast(?) Australian Covid-19 Trial Victor Chang Cardiac Research Institute
|
|
idontknow
|
86 |
44K |
12 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
86
|
44K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Grunenthal and MSB Enter Strategic Partnership for Back Pain
|
|
idontknow
|
162 |
85K |
3 |
02/05/20 |
02/05/20 |
ASX - By Stock
|
162
|
85K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
idontknow
|
17K |
6.8M |
5 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
17K
|
6.8M
|
5
|
|